E3 PreliminaryPreliminaryPEM ?Peer-reviewedMachine draft
Sporadic myalgic encephalomyelitis in a rural practice.
Keighley, B D, Bell, E J · The Journal of the Royal College of General Practitioners · 1983
Quick Summary
This study from 1983 examined 20 patients in a rural area who had long-lasting, hard-to-define illnesses. Researchers tested their blood for viral infections and found that 16 of these patients had high levels of Coxsackie B virus antibodies. Thirteen of these patients appeared to have myalgic encephalomyelitis (ME), while three had mainly heart-related symptoms. The findings suggest that a viral infection might be connected to ME, though the exact cause remains unclear.
Why It Matters
This early study provides historical evidence linking Coxsackie B virus to ME/CFS, contributing to decades of investigation into infectious triggers of the illness. It highlights that ME was recognized as a distinct clinical entity worthy of systematic investigation in primary care, helping establish the disease's legitimacy in medical literature. The findings have influenced subsequent research exploring viral reactivation and post-viral illness mechanisms in ME/CFS.
Observed Findings
- Elevated Coxsackie B virus titres detected in 16 of 20 patients (80%) with chronic undifferentiated illness
- 13 patients with elevated titres presented with ME-like symptoms
- 3 patients with elevated titres presented primarily with cardiovascular symptoms
- All 20 patients had chronic, ill-defined illnesses resistant to routine investigation
Inferred Conclusions
- Coxsackie B virus may have a viral aetiology in ME/CFS based on serological findings
- ME represents a distinct clinical entity separable from other chronic illnesses in primary care
- Viral infection may trigger both neurological and cardiovascular symptom patterns
Remaining Questions
- Does elevated Coxsackie B titres represent active infection or past exposure, and does this distinction matter for disease pathogenesis?
- Why do some patients with elevated titres develop neurological symptoms while others develop cardiovascular symptoms?
- What is the prevalence of similar Coxsackie B titres in asymptomatic controls from the same population?
- Does identifying viral markers early in disease course help predict prognosis or inform treatment strategies?
What This Study Does Not Prove
This study does not prove that Coxsackie B virus causes ME/CFS, only that an association exists in this small sample. The absence of control data from healthy individuals prevents determination of whether these antibody titres are unusually elevated or represent normal background seropositivity. The study's small size and lack of long-term follow-up limit conclusions about whether viral markers predict disease course or recovery.
Tags
Symptom:PainFatigue
Biomarker:Autoantibodies
Phenotype:Infection-Triggered
Method Flag:PEM Not DefinedWeak Case DefinitionNo ControlsSmall SampleExploratory Only
Metadata
- PMID
- 6310105
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026